-+ 0.00%
-+ 0.00%
-+ 0.00%

Rakovina Therapeutics appoints Prof. Petra Hamerlik to board of directors

PUBT·09/10/2026 08:00:34
Listen to the news
Rakovina Therapeutics appoints Prof. Petra Hamerlik to board of directors
  • Rakovina Therapeutics appointed Prof. Petra Hamerlik to its board at the Aug. 18, 2026 annual shareholder meeting.
  • Hamerlik chairs Translational Neuro-Oncology at the University of Manchester.
  • She served on Rakovina’s scientific advisory board since Nov. 20, 2023.
  • Previous roles include Principal Scientist, CNS Cancer Bioscience Lead at AstraZeneca, focused on brain-penetrant DNA repair inhibitors.
  • Earlier, she led a brain tumor biology lab at the Danish Cancer Research Centre, serving as Associate Professor at the University of Copenhagen.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rakovina Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609100400PRIMZONEFULLFEED9824185) on September 10, 2026, and is solely responsible for the information contained therein.